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Clinical Question 
Which treatments for persistent otitis media with effusion are beneficial? 
Evidence-Based Answer 
Treatments such as antibiotics, steroids, antihistamines/decongestants, and mucolytics afford no 
long-term benefit in the treatment of patients with otitis media with effusion (OME). [Strength of 
recommendation: A] Surgical treatments such as ventilation tubes and adenoidectomy improve 
hearing. [Strength of recommendation: A] However, surgery has conflicting effects on 
improving language development and behavior. [Strength of recommendation: B] There is 
inconclusive evidence that autoinflation of the eustachian tube with a nasal balloon improves 
resolution of OME. [Strength of recommendation: B] 
Evidence Summary 
OME is defined as middle ear effusion without acute inflammation. Many treatments have been 
recommended, although data supporting them are limited. 
The results of three meta-analyses1-3 showed that antibiotics increased the resolution of OME in 
the short-term (less than one month). However, the results of a conflicting meta-analysis4 of only 
higher quality, placebo-controlled studies showed that antibiotic therapy resulted in no 
significant difference compared with placebo. One meta-analysis3 looked at outcomes beyond 
one month and showed no significant difference in resolution of OME. 
The results of a well-designed systematic review5 of the use of steroids in patients with OME 
found that oral and nasal steroids do not have any significant benefit in the long-term (more than 
two weeks) when used alone or with antibiotics. A subsequent randomized controlled trial6 
(RCT) of oral steroids given with antibiotics reached similar conclusions. 
The results of meta-analyses on antihistamines/decongestants1 and mucolytics7 showed no 
benefit in clearance of OME. Another meta-analysis8 looked at opening the eustachian tubes by 
autoinflation with a nasal balloon. The methods of this meta-analysis were unclear, and the 
studies were generally of low quality. However, within a homogenous subgroup of three RCTs, 
the odds ratio for improvement of OME with autoinflation was 3.5 (95 percent confidence 
interval, 2.0 to 6.1). The number needed to treat was three. Unblinded outcome assessments led 
the authors of the meta-analysis to not recommend autoinflation for clinical practice.  
Surgical options include ventilation tubes, adenoidectomy, and tonsillectomy. The results of a 
systematic review9 of children with OME showed slight improvement (less than 12 dB) in 
hearing with the use of ventilation tubes or adenoidectomy alone. Combining the procedures 
offered little additional benefit. There were no data supporting tonsillectomy in the treatment of 
OME. A subsequent RCT10 of children with OME confirmed this conclusion, showing a 5 to 6 
dB improvement in hearing with ventilation tubes at six and 12 months postprocedure. The 
results of two additional RCTs11,12 using the same group of children showed that early insertion 
of ventilation tubes improves language development and decreases behavior problems at nine 
months postprocedure compared with watchful waiting. However, 85 percent of the children in 
the watchful-waiting group received ventilation tubes by 18 months, and there no longer were 
significant differences in outcomes. 
It is important to note that the inclusion criteria for these RCTs were baseline disruptions to 
speech, language, learning, and behavior. The results of other RCTs without these inclusion 
criteria showed no difference in language development or quality of life with early insertion of 
ventilation tubes versus watchful waiting for periods of six to 12 months. Furthermore, the 
majority of children in the watchful-waiting groups in these latter studies avoided surgery by the 
end of the follow-up periods.13-17 
Recommendations from Others 
A recent evidence-based practice guideline18 from the American Academy of Family 
Physicians, the American Academy of Pediatrics, and the American Academy of 
Otolaryngology-Head and Neck Surgery recommends against the use of antibiotics, steroids, 
antihistamine/decongestants, mucolytics, and autoinflation in the routine treatment of OME. 
Surgery for persistent OME should be reserved for use in children with significant hearing loss, 
persistent symptoms, risk factors for developmental difficulties, or structural damage to the 
tympanic membrane or middle ear. Antibiotics, with or without steroids, can be considered if the 
parents or caregivers are strongly opposed to surgery. 
Clinical Commentary 
Many patients and parents desire active treatment of OME, and treatment is still advocated by 
many physicians on the basis of habit, anecdote, or tradition. Therefore, it may be difficult for 
some physicians to not treat OME. Nevertheless, the evidence does not support most treatments. 
Instead of prescribing medicines, physicians must develop tracking and intervention systems to 
monitor children with OME over time and recognize complications such as significant hearing 
loss and developmental delays. Surgery should be considered for patients with these conditions. 
However, the optimal timing for surgery is unknown. 
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